The critiques raised by the Skeptic, Domain Expert, and Falsifier represent valid concerns about current therapeutic paradigms, but they converge on an opportunity rather than a dead end. The fundamental issue is that **existing approaches attempt to target TDP-43 protein directly, forcing an impossible choice between pathological inhibition and lethal loss of essential function**. My proposed RNA-guided precision therapeutics circumvent this paradox by targeting the *differential RNA interactom
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
Evidence
0.55
Novelty
0.60
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.00
KG Connect
0.50
Score Breakdown
Dimension
Advancing Beyond Traditional D
Mechanistic
0.600
Evidence
0.550
Novelty
0.600
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.000
KG Connect
0.500
Evidence
Advancing Beyond Traditional Druggability Through RNA-Guided